{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:55:29Z","timestamp":1772888129263,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica (INCT-NanoBiofar)"},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-01778-2014"],"award-info":[{"award-number":["CBB-APQ-01778-2014"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-467640\/2014-9"],"award-info":[{"award-number":["APQ-467640\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.molimm.2016.06.014","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T18:32:43Z","timestamp":1467657163000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection"],"prefix":"10.1016","volume":"76","author":[{"given":"Mariana C.","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourena E.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia M.R.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria R.S.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tha\u00eds T.O.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.P.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2016.06.014_bib0005","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/IAI.61.7.2952-2959.1993","article-title":"Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis","volume":"61","author":"Afonso","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2016.06.014_bib0010","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2012.05.075","article-title":"Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis","volume":"30","author":"Agallou","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2016.06.014_bib0015","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2016.06.014_bib0020","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.molimm.2016.06.014_bib0025","doi-asserted-by":"crossref","first-page":"e0003557","DOI":"10.1371\/journal.pntd.0003557","article-title":"Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis","volume":"9","author":"Baharia","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2004.03.097","article-title":"Leishmania donovani induces interferon regulatory factor in murine macrophages: a host defense response","volume":"317","author":"Balaraman","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2016.06.014_bib0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","article-title":"New vaccines for neglected parasitic diseases and dengue","volume":"162","author":"Beaumier","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.molimm.2016.06.014_bib0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000109118","article-title":"Eukaryotic initiation factor 5A activity and HIV-1 Rev function","volume":"6","author":"Bevec","year":"1997","journal-title":"Biol. Signals."},{"key":"10.1016\/j.molimm.2016.06.014_bib0045","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1017\/S0031182000076678","article-title":"Genetic susceptibility to leishmanial infections: studies in mice and man","volume":"112","author":"Blackwell","year":"1996","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2016.06.014_bib0050","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jprot.2014.05.010","article-title":"Proteomic analysis of the soluble proteomes of miltefosine-sensitive and \u2212resistant Leishmania infantum chagasi isolates obtained from Brazilian patients with different treatment outcomes","volume":"108","author":"Carnielli","year":"2014","journal-title":"J. Proteomics."},{"key":"10.1016\/j.molimm.2016.06.014_bib0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation","volume":"4","author":"Carri\u00f3n","year":"2011","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.molimm.2016.06.014_bib0060","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.micinf.2010.06.008","article-title":"Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB\/c mice against Leishmania chagasi and Leishmania amazonensis challenge","volume":"12","author":"Ch\u00e1vez-Fumagalli","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.molimm.2016.06.014_bib0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000109115","article-title":"Biochemistry and function of hypusine formation on eukaryotic initiation fator 5A","volume":"6","author":"Chen","year":"1997","journal-title":"Biol. Signals."},{"key":"10.1016\/j.molimm.2016.06.014_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3835(96)04287-5","article-title":"Effects of inhibitors of deoxyhypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells","volume":"105","author":"Chen","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molimm.2016.06.014_bib0075","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2016.06.014_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0085","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/pr101286y","article-title":"Analysis of Leishmania chagasi by 2-D difference gel electrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine","volume":"10","author":"Costa","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.molimm.2016.06.014_bib0090","doi-asserted-by":"crossref","first-page":"e110014","DOI":"10.1371\/journal.pone.0110014","article-title":"Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis","volume":"9","author":"Costa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2016.06.014_bib0095","first-page":"1","article-title":"Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection","volume":"23","author":"Costa","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2016.06.014_bib0100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbrc.2006.06.119","article-title":"Molecular modeling of the human eukaryotic translation initiation factor 5A (eIF5A) based on spectroscopic and computational analyses","volume":"347","author":"Costa-Neto","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2016.06.014_bib0105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis: current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1586\/erv.12.50","article-title":"Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis","volume":"11","author":"Das","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.molimm.2016.06.014_bib0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2004.12.001","article-title":"Translation initiation in Leishmania major: characterization of multiple eIF4F subunit homologues","volume":"140","author":"Dhalia","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0125","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00465-15","article-title":"Proteins selected in Leishmania (Viannia) braziliensis by an immunoproteomic approach with potential serodiagnosis applications for tegumentary leishmaniasis","volume":"22","author":"Duarte","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-3024.2012.01379.x","article-title":"Decrease in anti-leishmania IgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure","volume":"34","author":"Fagundes-Silva","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0135","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2016.06.014_bib0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0145","doi-asserted-by":"crossref","first-page":"e1596","DOI":"10.1371\/journal.pntd.0001596","article-title":"Canine skin and conjunctival swab samples for the detection and quantification of Leishmania infantum DNA in an endemic urban area in Brazil","volume":"6","author":"Ferreira","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2014.11.039","article-title":"Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum","volume":"33","author":"Fiuza","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2016.06.014_bib0155","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.pone.0000040","article-title":"Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology","volume":"1","author":"Forgber","year":"2006","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2016.06.014_bib0160","first-page":"147","article-title":"Homeostasis of specific imune response in clinically cured cutaneous leishmaniasis subjects due to Leishmania (Viannia) braziliensis","volume":"42","author":"Gomes-Silva","year":"2009","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.molimm.2016.06.014_bib0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-2478(90)90083-3","article-title":"Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from l-arginine by macrophages and hepatocytes","volume":"25","author":"Green","year":"1990","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2016.06.014_bib0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4269\/ajtmh.1991.45.281","article-title":"Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection","volume":"45","author":"Gutierrez","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.molimm.2016.06.014_bib0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1017\/S0031182013001959","article-title":"Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB\/c mice","volume":"141","author":"Joshi","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2016.06.014_bib0180","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/S0021-9258(17)41723-6","article-title":"Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae","volume":"269","author":"Kang","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2016.06.014_bib0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.molimm.2016.06.014_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(98)00132-1","article-title":"T-cell response in human leishmaniasis","volume":"65","author":"Kharazmi","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2016.06.014_bib0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pim.12287","article-title":"Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis","volume":"37","author":"Lage","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0200","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.actatropica.2016.03.011","article-title":"Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species","volume":"158","author":"Lage","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.molimm.2016.06.014_bib0205","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0210","doi-asserted-by":"crossref","first-page":"e0141496","DOI":"10.1371\/journal.pone.0141496","article-title":"Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of Leishmania infantum against visceral leishmaniasis","volume":"10","author":"Martins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2016.06.014_bib0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0102-311X1994000800014","article-title":"Tegumentary and visceral leishmaniasis in Brazil: emerging anthropozoonosis and possibilities for their control","volume":"10","author":"Marzochi","year":"1994","journal-title":"Cad. Saude Publica"},{"key":"10.1016\/j.molimm.2016.06.014_bib0220","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0225","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0230","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2016.06.014_bib0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7555\/JBR.27.20120064","article-title":"Development of Leishmania vaccines: predicting the future from past and present experience","volume":"27","author":"Mutiso","year":"2013","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.molimm.2016.06.014_bib0240","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00436-011-2628-5","article-title":"Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites","volume":"110","author":"Oliveira","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.molimm.2016.06.014_bib0245","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2016.06.014_bib0250","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s005990050076","article-title":"Inducible nitric oxide synthase and nitric oxide production in Leishmania infantum-infected human macrophages stimulated with interferon-gamma and bacterial lipopolysaccharide","volume":"29","author":"Panaro","year":"1999","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.molimm.2016.06.014_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000109117","article-title":"Hypusine is essential for eukaryotic cell proliferation","volume":"6","author":"Park","year":"1997","journal-title":"Biol. Signals"},{"key":"10.1016\/j.molimm.2016.06.014_bib0260","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.vaccine.2012.12.071","article-title":"Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis","volume":"31","author":"Ram\u00edrez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2016.06.014_bib0265","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2014.00272","article-title":"Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease","volume":"5","author":"Roatt","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0275","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1128\/MCB.11.6.3105","article-title":"Translation initiation fator 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae","volume":"11","author":"Schnier","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0280","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0074-02762004000300001","article-title":"Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review","volume":"99","author":"Silveira","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.molimm.2016.06.014_bib0285","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0290","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-3024.2011.01318.x","article-title":"Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB\/c mice","volume":"33","author":"Soudi","year":"2011","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0295","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"St\u00e4ger","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2016.06.014_bib0300","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor \u03b1 signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"St\u00e4ger","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2016.06.014_bib0305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tplants.2004.02.008","article-title":"Regulation of senescence by eukaryotic translation initiation factor 5A: implications for plant growth and development","volume":"9","author":"Thompson","year":"2004","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.molimm.2016.06.014_bib0310","first-page":"22","article-title":"Control of the leishmaniases","author":"World Health Organization","year":"2010","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.molimm.2016.06.014_bib0315","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.molimm.2016.06.014_bib0320","doi-asserted-by":"crossref","first-page":"e2751","DOI":"10.1371\/journal.pntd.0002751","article-title":"Enhanced protective efficacy of nonpathogenic recombinant Leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen","volume":"8","author":"Zahedifard","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2016.06.014_bib0325","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/emboj\/17.10.2914","article-title":"A single amino acid substitution in yeast eIF-5A results in mRNA stabilization","volume":"17","author":"Zuk","year":"1998","journal-title":"EMBO J."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158901630116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158901630116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:31:30Z","timestamp":1692415890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158901630116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":65,"alternative-id":["S016158901630116X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2016.06.014","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2016.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}